Actively Recruiting
Evaluating a Ketogenic Diet Intervention for Adults with Bipolar Depression An Open-Label Clinical Trial by Mayo Clinic
Led by Mayo Clinic · Updated on 2026-08-17
30
Participants Needed
1
Research Sites
17 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effects of a ketogenic diet on individuals with bipolar depression. This trial aims to understand how therapeutic precision ketosis relates to clinical symptoms and cardiometabolic health in people diagnosed with bipolar I or II disorder or bipolar schizoaffective disorder. The study focuses on treatment outcomes related to mood, metabolic measures, and inflammation. Participants will follow a modified ketogenic diet supported by structured, intensive guidance. They will also attend weekly behavioral support interviews with a psychiatrist to monitor mental health and mood stability. This open-label trial involves a single group of participants undergoing this dietary intervention over a six-month period. During the study, participants will undergo assessments of depressive symptoms, anxiety, psychosocial functioning, well-being, insulin resistance, mitochondrial function, inflammatory markers, and vascular health at the start and after six months. Researchers will track response and remission rates, clinically significant improvements, and the prevalence of disordered eating. Safety and health monitoring will continue throughout the study to evaluate the impact of the ketogenic diet on bipolar depression and associated cardiometabolic factors.
CONDITIONS
Brief Title
Ketogenic Intervention for Bipolar Depression
Research Team
K
Karin Lindstrom, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here